Top Researchers
Top Medicine Researchers at Duke University for 2026
Duke University’s recent Medicine research spans a wide range of clinical questions, from cardiovascular care and respiratory medicine to surgery, epidemiology, and imaging. Looking across the last year of output, a clear picture emerges of a research community balancing patient-centered clinical studies with methods that help refine how care is measured, delivered, and improved.
Below, you’ll find a snapshot of researchers whose recent work has been especially active, along with the themes that appear most often across their publications.
Featured Researchers
Marat Fudim
Marat Fudim’s recent work at Duke University centers on cardiology and biomedical engineering, including studies on GLP-1 receptor agonists in heart failure, clinical neurocardiology, and cerebral blood flow in orthostatic intolerance.
Activity over the last year: 49 indexed journal articles.
Top publications:
- Efficacy of GLP-1 Receptor Agonists in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis (Feb 2025)
- Clinical neurocardiology: defining the value of neuroscience‐based cardiovascular therapeutics – 2024 update (Mar 2025)
- Cerebral Blood Flow in Orthostatic Intolerance (Feb 2025)
Stephen J. Greene
Stephen J. Greene’s Duke University publications focus on cardiology, diabetes, and respiratory medicine, with recent attention to heart failure outcomes, GLP-1 receptor agonists, and long-term heart failure statistics.
Activity over the last year: 33 indexed journal articles.
Top publications:
- Efficacy of GLP-1 Receptor Agonists in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis (Feb 2025)
- HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America (Sep 2025)
- Get With The Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead (May 2025)
Brian Mac Grory
Brian Mac Grory’s recent Duke University work spans epidemiology, pulmonary and respiratory medicine, and neurology, including research on dementia trends, acute ischemic stroke treatment, and carotid stenting.
Activity over the last year: 38 indexed journal articles.
Top publications:
- Incidence and prevalence of dementia among US Medicare beneficiaries, 2015-21: population based study (May 2025)
- Short-Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute Ischemic Stroke (Mar 2025)
- Emergent Carotid Stenting During Thrombectomy in Tandem Occlusions Secondary to Dissection: A STOP-CAD Secondary Study (Jan 2025)
Jerrold H. Levy
Jerrold H. Levy’s Duke University research emphasizes critical care, internal medicine, and biochemistry, with recent publications on disseminated intravascular coagulation, coagulopathic bleeding, and the physiology of temperature change.
Activity over the last year: 29 indexed journal articles.
Top publications:
- Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation (Apr 2025)
- Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery (Mar 2025)
- Impact of hyper- and hypothermia on cellular and whole-body physiology (Jan 2025)
Christopher I. Shaffrey
Christopher I. Shaffrey’s Duke University output concentrates on surgery, pathology and forensic medicine, and biomedical engineering, including studies on adult spinal deformity, operative outcomes, and cervical extension reserve.
Activity over the last year: 46 indexed journal articles.
Top publications:
- Operative vs Nonoperative Treatment for Adult Symptomatic Lumbar Scoliosis at 8-Year Follow-Up (Apr 2025)
- Iatrogenic posterior translation of the construct at the uppermost instrumented vertebrae is associated with proximal junctional kyphosis (Feb 2025)
- Quantifying the Importance of Upper Cervical Extension Reserve in Adult Cervical Deformity Surgery and Its Impact on Baseline Presentation and Outcomes (Jun 2025)
Pamela S. Douglas
Pamela S. Douglas’s Duke University publications bring together imaging, cardiology, and surgery, with recent work on cardiovascular risk prediction and plaque, inflammation, and myocardial injury in people with HIV.
Activity over the last year: 43 indexed journal articles.
Top publications:
- Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE (Jan 2025)
- Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy (May 2025)
- Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV (Apr 2025)
Nosayaba Osazuwa‐Peters
Nosayaba Osazuwa-Peters’s Duke University research connects otorhinolaryngology, epidemiology, and oncology, including studies of thyroid cancer trends, HPV vaccine progress, and vaccine uptake.
Activity over the last year: 30 indexed journal articles.
Top publications:
- Thyroid Cancer Incidence and Trends in United States and Canadian Pediatric, Adolescent, and Young Adults (Apr 2025)
- Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity (Sep 2025)
- The Affordable Care Act and change in human papillomavirus (HPV) vaccine uptake in the United States (Feb 2025)
Daniel J. George
Daniel J. George’s Duke University work bridges pulmonary and respiratory medicine, cancer research, and imaging, with recent studies on metastatic prostate cancer, treatment patterns, and renal cell carcinoma trials.
Activity over the last year: 30 indexed journal articles.
Top publications:
- Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study (Oct 2025)
- Real-world treatment patterns and outcomes in advanced prostate cancer: A cohort study using the prostate cancer disease observation (PRECISION) data platform. (Feb 2025)
- Ipilimumab and nivolumab in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated on the phase 3 PDIGREE (Alliance A031704) trial: Results from Step 1 analysis. (May 2025)
What Duke University's Medicine Community Is Working On
Across Duke University’s recent Medicine output, the most common themes are cardiology and cardiovascular medicine, pulmonary and respiratory medicine, biomedical engineering, epidemiology, and surgery. That mix suggests an active community focused on both major disease areas and the tools needed to study them well: risk prediction, outcomes research, procedural refinement, and biologically informed treatment strategies. The overall pattern points to work that is clinically grounded while still reaching into measurement, modeling, and device-informed approaches.- Cardiology and Cardiovascular Medicine - seen across 3 of the featured researchers
- Pulmonary and Respiratory Medicine - seen across 3 of the featured researchers
- Biomedical Engineering - seen across 2 of the featured researchers
- Epidemiology - seen across 2 of the featured researchers
- Surgery - seen across 2 of the featured researchers
These recent publications show Duke University researchers working across complementary areas of medicine, with strong attention to practical questions in diagnosis, treatment, and outcomes. Explore the featured names below to see how their interests connect across specialties, and consider using Resub to support citation discovery, manuscript formatting, and submission preparation in your own workflow.
Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.